Mumbai/New Delhi, 15 December 2025 – Indian shares started Monday’s session in the red on weak global cues, leading to a cautious stance for midcap and high-beta stocks, which have already seen sharp fluctuations this month. [1]
Two stocks that are getting a lot of attention 15.12.2025 At opposite ends of the market-cap spectrum are: Dixon Technologies (India)The country’s most closely watched listed electronics manufacturing services (EMS) sport a massive correction, and lemon chemicalA microcap chemicals manufacturer that is in the news in retail circles for its long-term “buy and hold” statement.
Below is what’s driving the conversation today, what’s been confirmed in the latest reporting, and what investors are looking forward to.
Dixon Technologies: From December selloff to “moment test” in Monday trading
Dixon Technologies in focus after stock plunged on Dec. 15 declined sharply in the last month And is trading well below its record high. Earlier reports indicated a mixture of Profit-booking, competitive pressures, guidance concerns and changes in shareholding Stocks fell as major reasons. [2]
Where is Dixon’s share price on December 15, 2025
But in the pre-opening signal BSEDixon was seen around ₹13,426 But 09:44 (up marginally on the day), reflecting an attempt at stabilization after last week’s volatility. [3]
The Economic Times market snapshot around mid-morning was also estimated to be near Dixon ₹13,443 (09:53 AM IST), with updated valuation metrics. [4]
Why it matters: For a stock that has been representative of India’s market leadership for the contract manufacturing theme, the first half of December has shifted the debate from “growth at any cost” to “how much uncertainty already exists”.
What’s making Dixon “sick,” according to the latest reporting
Many factors have been cited for the pullback, and the main one for investors is that spreads Both fundamentals and positions,
1) Profit booking after long term and weak sentiment in mid/smallcaps
Upstox notes that amid the broader correction and 2025’s underperformance for many winners, investors have been cashing out Dixon is among the names facing “exhaustion” after years of strong gains. [5]
2) Reduction in stake of promoter and foreign investor spoiled the sentiment
Recent coverage highlights a specific overhang Decline in promoter and FII holdings In recent quarters, that could weigh on sentiment even when operating performance has been stable – as markets read this as low confidence at elevated valuations. [6]
3) Competitive pressures and changes in smartphone manufacturing allocation
Another matter of concern increased competition-including reports of smartphone brands diversifying into manufacturing partners – with the view that the “China+1” tailwind does not automatically translate into uninterrupted share gains for any one Indian EMS player. [7]
4) Guidance and near-term visibility questions
Upstox also pointed out Revised or conservative guidance The stock is being weighed down as part of the narrative, lending credence to the idea that the market is readjusting expectations. [8]
Sector-wide shock hitting EMS stocks: Kaynes’ spillover effect
Dixon’s fall did not happen alone. In early December, a sell-off in peer Kaynes Technology That contributed to broad risk-off sentiment in EMS names including Dixon, Amber Enterprises and PG Electroplast, dragging the entire basket down intraday. [9]
take away: Even investors excited about the transformation of the manufacturing sector in India have started considering EMS as cycle-Sector sentiment and valuation resets are moving faster than business fundamentals.
Why are brokerages still talking bullish – and what is the “Vivo JV” risk?
Despite bearish price action, a key 15th December The news hook is that major institutions are still publicly constructive on Dixon.
Times of India “Top Stocks to Buy on December 15” list repeated it CLSA maintains one to overcome stance with a ₹18,800 Target, acknowledging that the stock has improved FY27 EPS concerns and that Vivo JV A pending catalyst remains. [10]
Business Today adds more color to the same debate:
- Dixon was in one Bullish trend for two sessions At the time of reporting and had bounced ~10.5% from a 52-week low near ₹12,133 Arrived on 11th December. [11]
- Yet it is still in a broad weak zone, trading below several moving averages and flaring. Oversold RSI (~29.7)-A technical signal that sometimes occurs before a relief rally or base-building phase. [12]
- The article also highlights a key uncertainty: approval delays and earnings-mix risks associated with the Vivo JV, including potential negative impacts on EPS assumptions depending on how volumes materialize. [13]
What is “Press Note 3” and why does it matter here?
Broker notes and market coverage are frequently mentioned press note 3 In the context of joint venture approval where ownership, beneficial ownership, or investment origination triggers India’s government-approval route.
The Press Information Bureau of India has already made it clear that Press Note 3 (2020) The FDI policy was amended to require investment from entities in countries sharing land borders with India – or where the beneficial owners are from such countries – government approvalAnd some ownership transfers may also require approval. [14]
In terms of market: Any timeframe uncertainty around regulatory approvals could send a high-multiple stock moving higher, as it alters the confidence level in future volume ramps and earnings trajectory.
What to look forward to for Dixon Technologies (Practical Checklist)
From today’s reporting thread, the near-term Dixon narrative depends on Three Dynamic Pieces:
- JV/Approval Clarity (Including any timeline updates associated with Press Note 3-linked processes). [15]
- EPS visibility for FY27 Since broker models absorb potential delays or low medium-term certainty. [16]
- Can a stock form a basis? Technically it continues to be oversold, or sold in rallies. [17]
Lime Chemicals: Microcap volatility meets the “5-year bullish” retail narrative
While Dixon sits in institutional portfolios and headline brokerage notes, Lime Chemicals (BSE: 507759) One is being watched for a very different reason: this is a microcap where price action can move quickly at low liquidity – and where extensive internet commentary sometimes runs ahead of formal research coverage.
Lime Chemicals share price on December 15, 2025
Lime Chemicals seen trading around on Upstox’s stock page ₹12.99 But 15 December 2025including day limit ₹11.53 (less) And ₹12.99 (High) At the time of update, and around market cap single-digit-crore Category. [18]
The same page also points to a Retail-heavy shareholding (with retail and “other” investors making up the bulk of reported holdings), a setup that often increases volatility when sentiment changes. [19]
What exactly do lime chemicals do?
Lime Chemicals is described as a chemical manufacturing company. Calcium carbonate and related derivativesUsed in applications such as toothpaste, pharmaceuticals, PVC pipe, rubber, paper and paintamong others. [20]
Fundamentals reality check: Recent results show pressure
Latest available income coverage (standalone results) reports from Moneycontrol:
- Net sales of ₹1.46 crore For September 2025Below 38.98% per annum (From ₹2.38 crore in September 2024)
- A Net loss of ₹0.16 crore For September 2025
- Negative EBITDA for the quarter [21]
This matters because long-term “bullish” narratives in microcaps ultimately need a bridge from the story to the numbers – either through margin expansion, steady demand, or the operational improvements that consistently show up in quarterly reporting.
Are there “analysts” covering Lime Chemicals?
A key point that is often missed in discussions of social-media style formal analyst coverage,
Simply Wall St’s page on Lime Chemicals explains it clearly There is not enough analyst coverage To forecast growth and revenue, listing Analyst Coverage: None, [22]
Practical implications: When you see content claiming “analysts are bullish” on microcaps, it may be referring to general market commentators rather than a tracked set of brokerage analysts who publish formal models and target prices.
Corporate calendar: when to expect the next official update
For investors tracking microcaps, scheduled reporting dates and board meeting cadence matter Official filings can be the highest quality catalysts,
Lime Chemicals board meeting dates in 2025 are listed in the corporate section of Moneycontrol, including the quarterly results meeting 14 November 2025 And quarterly/audited-result meetings of the year before. [23]
The Economic Times updates page also shows the flow of BSE-related announcements and board meeting information till 2025. [24]
Last Line on December 15: Two very different “in focus” stories
- Dixon Technologies (NSE: DIXON) A large, liquid EMS bellwether is trying to settle after a sharp correction, which balances broker optimism in the market (including a reiterated ₹18,800 target today) against real uncertainties around approvals, medium-term visibility and FY27 earnings expectations. [25]
- Lime Chemicals (BSE: 507759) Microcaps are where today’s price action is colliding with the long-term retail narrative – yet recent financials show pressure and formal analyst coverage appears limited, making risk management and filing discipline particularly important. [26]
Markets move quickly; All prices mentioned above are as quoted in the sources quoted during the December 15, 2025 session and may change after publication. [27]
Reference
1. timesofindia.indiatimes.com, 2. upstox.com, 3. www.moneycontrol.com, 4. economictimes.indiatimes.com, 5. upstox.com, 6. upstox.com, 7. upstox.com, 8. upstox.com, 9. m.economictimes.com, 10. timesofindia.indiatimes.com, 11. www.businesstoday.in, 12. www.businesstoday.in, 13. www.businesstoday.in, 14. www.pib.gov.in, 15. www.businesstoday.in, 16. timeofindia.indiatimes.com, 17. www.businesstoday.in, 18. upstox.com, 19. upstox.com, 20. www.livemint.com, 21. www.moneycontrol.com, 22. justwall.st, 23. www.moneycontrol.com, 24. economictimes.indiatimes.com, 25. timesofindia.indiatimes.com, 26. upstox.com, 27. www.moneycontrol.com